Author

Theodoros Michelakos

Surgery Resident, Massachusetts General Hospital / Harvard Medical School - Cited by 1,609 - surgical oncology - tumor immunology - statistics

Biography

Theodoros Michelakos is a General Surgery resident and Research Fellow at the Massachusetts General Hospital/Harvard Medical School. He obtained his MD degree at the University of Athens, Greece. His research focuses on surgical oncology and immuno-oncology with special interest in hepatic, pancreatic and biliary malignancies.  
Title
Cited by
Year
Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX
T Michelakos, I Pergolini, C Fernández-del Castillo, KC Honselmann, ...Annals of surgery 269 (4), 733-740, 2019201
281
2019
B7-H3: an attractive target for antibody-based immunotherapy
F Kontos, T Michelakos, T Kurokawa, A Sadagopan, JH Schwab, ...Clinical Cancer Research 27 (5), 1227-1235, 2021202
127
2021
Defective HLA class I antigen processing machinery in cancer
L Cai, T Michelakos, T Yamada, S Fan, X Wang, JH Schwab, CR Ferrone, ...Cancer Immunology, Immunotherapy 67, 999-1009, 2018201
68
2018
Role of tumor-associated macrophages in the clinical course of pancreatic neuroendocrine tumors (PanNETs)
L Cai, T Michelakos, V Deshpande, KS Arora, T Yamada, DT Ting, ...Clinical Cancer Research 25 (8), 2644-25, 2019201
65
2019
Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy
T Michelakos, L Cai, V Villani, F Sabbatino, F Kontos, ...JNCI: Journal of the National Cancer Institute, 2020202
41
2020
Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer
M Weniger, T Hank, M Qadan, D Ciprani, T Michelakos, H Niess, ...British Journal of Surgery, 2020202
26
2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and is Measurable with Collagen-Targeted Molecular MRI
DJ Erstad, M Sojoodi, MS Taylor, VC Jordan, CT Farrar, AL Axtell, ...Clinical Cancer Research, 2020202
22
2020
Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation
K Wang, T Michelakos, B Wang, Z Shang, AB DeLeo, Z Duan, ...Cancer letters 505, 37-48, 2021202
19
2021
Human leukocyte antigen class I antigen-processing machinery upregulation by anticancer therapies in the era of checkpoint inhibitors: a review
A Sadagopan, T Michelakos, G Boyiadzis, C Ferrone, S FerroneJAMA oncology 8 (3), 462-473, 2022202
15
2022
Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival
T Michelakos, F Kontos, Y Sekigami, M Qadan, L Cai, O Catalano, ...Journal of Gastrointestinal Surgery, 2020202
11
2020
B7-H3 targeted antibody-based immunotherapy of malignant diseases
T Michelakos, F Kontos, O Barakat, L Maggs, JH Schwab, CR Ferrone, ...Expert opinion on biological therapy 21 (5), 587-602, 2021202
10
2021
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
T Michelakos, F Kontos, T Kurokawa, L Cai, A Sadagopan, D Krijgsman, ...Journal for Immunotherapy of Cancer 10 (3), 2022202
7
2022
Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX …
Y Sekigami, T Michelakos, C Fernandez-Del Castillo, F Kontos, M Qadan, ...Annals of Surgical Oncology, 2021202
7
2021
Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance Status
G Tsiotos, N Ballian, T Michelakos, F Milas, P Ziogou, ...Journal of Pancreatic Cancer, 2019201
7
2019
Hepatocellular carcinoma in transplantable child-pugh a cirrhotics: should cost affect resection vs transplantation?
T Michelakos, D Xourafas, M Qadan, R Pieretti-Vanmarcke, L Cai, ...Journal of Gastrointestinal Surgery 23, 1135-1142, 2019201
6
2019
Conditional survival in resected pancreatic ductal adenocarcinoma patients treated with total neoadjuvant therapy
T Michelakos, Y Sekigami, F Kontos, C Fernandez-del Castillo, M Qadan, ...Journal of Gastrointestinal Surgery, 1-12, 2021202
5
2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy
Y Noda, N Pisuchpen, ND Mercaldo, Y Sekigami, T Michelakos, A Parakh, ...European Radiology, 1-11, 2022202
5
2022
Orbezoar: a superabsorbent polymer causing small bowel obstruction in a toddler
T Michelakos, M Tanaka, MS Patel, DP RyanJournal of pediatric gastroenterology and nutrition 70 (2), e48, 2020202
5
2020
Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients
J Zheng, A Pulvirenti, AA Javed, T Michelakos, A Paniccia, KK Lee, ...Journal of the American College of Surgeons 235 (2), 315-330, 2022202
4
2022
Grading pancreatic neuroendocrine tumors via endoscopic ultrasound-guided fine needle aspiration: A multi-institutional study
AA Javed, A Pulvirenti, S Razi, J Zheng, T Michelakos, Y Sekigami, ...Annals of Surgery, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=GUbHxecAAAAJ&hl=en

Cited by
Citations 1609
h-index 19
i10-index 24
Recommended Journals
Open Access Journals